Total Payments
$9,418
2024 Payments
$681.12
Companies
31
Transactions
698
Medicare Patients
523
Medicare Billing
$35,404
Payment Breakdown by Category
Food & Beverage$8,483 (90.1%)
Gifts$880.00 (9.3%)
Education$54.91 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,483 | 691 | 90.1% |
| Gift | $880.00 | 3 | 9.3% |
| Education | $54.91 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,243 | 121 | $0 (2024) |
| ABBVIE INC. | $1,079 | 77 | $0 (2024) |
| Sekisui Diagnostics, LLC | $880.00 | 3 | $0 (2024) |
| Allergan, Inc. | $784.83 | 104 | $0 (2020) |
| Amgen Inc. | $714.38 | 46 | $0 (2023) |
| Lilly USA, LLC | $640.05 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $596.64 | 55 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $465.29 | 28 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $460.66 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $241.67 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $681.12 | 24 | Sekisui Diagnostics, LLC ($200.00) |
| 2023 | $1,190 | 50 | Sekisui Diagnostics, LLC ($300.00) |
| 2022 | $1,634 | 88 | Sekisui Diagnostics, LLC ($380.00) |
| 2021 | $1,974 | 141 | AbbVie Inc. ($403.62) |
| 2020 | $1,396 | 108 | Allergan, Inc. ($337.51) |
| 2019 | $1,025 | 97 | Amgen Inc. ($290.04) |
| 2018 | $861.77 | 112 | Novo Nordisk Inc ($202.89) |
| 2017 | $654.69 | 78 | Allergan Inc. ($153.89) |
All Payment Transactions
698 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: PAIN | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Oncology | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.46 | General |
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.45 | General |
| 06/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: PAIN | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: PAIN | ||||||
| 04/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $200.00 | General |
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Diabetes | ||||||
| 01/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Respiratory | ||||||
| 12/21/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 205 | 299 | $29,695 | $11,976 |
| 2022 | 6 | 173 | 298 | $32,664 | $12,760 |
| 2021 | 3 | 75 | 145 | $14,048 | $5,746 |
| 2020 | 3 | 70 | 150 | $14,968 | $4,922 |
Total Patients
523
Total Services
892
Medicare Billing
$35,404
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 42 | $7,980 | $3,755 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 70 | $12,250 | $3,112 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $4,400 | $2,638 | 60.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 80 | $2,000 | $647.85 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 20 | $1,700 | $632.88 | 37.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 24 | 24 | $504.00 | $493.92 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $525.00 | $425.00 | 81.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $336.00 | $272.00 | 81.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 66 | $10,902 | $5,134 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 81 | $10,875 | $4,280 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,070 | $1,334 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,827 | $1,032 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 21 | $1,565 | $700.21 | 44.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 47 | 97 | $2,425 | $279.37 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 57 | $9,348 | $4,308 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 25 | $3,125 | $1,249 | 40.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 31 | 63 | $1,575 | $189.00 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 62 | $10,168 | $3,772 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 26 | $3,250 | $965.00 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 28 | 62 | $1,550 | $184.80 | 11.9% |
About Dr. Malea Jensen, DO
Dr. Malea Jensen, DO is a Family Medicine healthcare provider based in West Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740241942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malea Jensen, DO has received a total of $9,418 in payments from pharmaceutical and medical device companies, with $681.12 received in 2024. These payments were reported across 698 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,483).
As a Medicare-enrolled provider, Jensen has provided services to 523 Medicare beneficiaries, totaling 892 services with total Medicare billing of $35,404. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location West Des Moines, IA
- Active Since 03/29/2006
- Last Updated 03/19/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740241942
Products in Payments
- Ozempic (Drug) $788.43
- UBRELVY (Drug) $709.50
- VRAYLAR (Drug) $496.75
- NURTEC ODT (Drug) $458.11
- XARELTO (Drug) $379.18
- FARXIGA (Drug) $328.58
- EMGALITY (Drug) $307.78
- JARDIANCE (Drug) $306.36
- EVENITY (Biological) $296.26
- Aimovig (Biological) $272.37
- BYSTOLIC (Drug) $241.97
- Kerendia (Drug) $237.87
- QULIPTA (Drug) $234.13
- AFREZZA (Drug) $218.74
- XIFAXAN (Drug) $199.53
- Livalo (Drug) $186.30
- INVOKANA (Drug) $166.74
- TRULICITY (Drug) $161.18
- TRINTELLIX (Drug) $152.54
- TRADJENTA (Drug) $144.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Des Moines
Basil Hassan, Md, MD
Family Medicine — Payments: $17,360
Family Medicine $17,360
Dawn Schissel, Md, MD
Family Medicine — Payments: $17,086
Family Medicine $17,086
Dale Grunewald, D.o, D.O
Family Medicine — Payments: $12,944
Family Medicine $12,944
Mr. Jeffrey Lenz, Md, MD
Family Medicine — Payments: $9,710
Family Medicine $9,710
Majed Barazanji, M.d, M.D
Family Medicine — Payments: $8,911
Family Medicine $8,911
Jeffrey Schoon, Do, DO
Family Medicine — Payments: $1,041
Family Medicine $1,041